AstraZeneca

IMED Report

I designed and artworked the annual report for AstraZeneca's Innovative Medicines and Early Development (IMED) unit in 2018. The unit focuses on new and innovative medicines and the facilities where they are engineered and developed.

The visual style had to appeal to those in the scientific branch of the company, whilst reflecting an optimistic and clean vision of the future. I managed content, image selection, designed bespoke visuals and produced the 35,000-word report.

Agency: Ruder Finn